This company is no longer active
Angion Biomedica Dirección
Dirección controles de criterios 3/4
Angion Biomedica's CEO is Jay Venkatesan, appointed in May 2018, they has a tenure of 5.08 years. Their total yearly compensation is $1.52M , comprised of 40% salary and 60% bonuses, including company stock and options. They directly owns 3.98% of the company’s shares, worth $1.20M. The average tenure of the management team and the board of directors is 3.5 years and 4.3 years respectively.
Información clave
Jay Venkatesan
Chief Executive Officer (CEO)
US$1.5m
Compensación total
| Porcentaje del salario del CEO | 40.0% |
| Permanencia del CEO | 5.1yrs |
| Participación del CEO | 4.0% |
| Permanencia media de la dirección | 3.5yrs |
| Promedio de permanencia en la Junta Directiva | 4.3yrs |
Actualizaciones recientes de la dirección
Recent updates
Companies Like Angion Biomedica (NASDAQ:ANGN) Could Be Quite Risky
Apr 27
Angion Biomedica (NASDAQ:ANGN) Will Have To Spend Its Cash Wisely
Jan 05We Think Angion Biomedica (NASDAQ:ANGN) Needs To Drive Business Growth Carefully
Sep 11Angion Biomedica GAAP EPS of -$0.30, revenue of $0.7M misses by $0.08M
Aug 15Angion to discontinue phase 2 trial of ANG-3070 in patients with kidney disease
Jun 29We Think Angion Biomedica (NASDAQ:ANGN) Can Afford To Drive Business Growth
Mar 19Angion Biomedica: Selling At Cash Value
Feb 07Angion Biomedica Corp.'s (NASDAQ:ANGN) Intrinsic Value Is Potentially 49% Above Its Share Price
Oct 05We're Hopeful That Angion Biomedica (NASDAQ:ANGN) Will Use Its Cash Wisely
Aug 18Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Mar 31 2023 | n/a | n/a | -US$29m |
| Dec 31 2022 | US$2m | US$608k | -US$39m |
| Sep 30 2022 | n/a | n/a | -US$17m |
| Jun 30 2022 | n/a | n/a | -US$24m |
| Mar 31 2022 | n/a | n/a | -US$32m |
| Dec 31 2021 | US$3m | US$587k | -US$55m |
| Sep 30 2021 | n/a | n/a | -US$98m |
| Jun 30 2021 | n/a | n/a | -US$100m |
| Mar 31 2021 | n/a | n/a | -US$104m |
| Dec 31 2020 | US$1m | US$570k | -US$80m |
| Sep 30 2020 | n/a | n/a | -US$67m |
| Dec 31 2019 | US$2m | US$473k | -US$41m |
Compensación vs. Mercado: Jay's total compensation ($USD1.52M) is above average for companies of similar size in the US market ($USD757.79K).
Compensación vs. Ingresos: Jay's compensation has been consistent with company performance over the past year.
CEO
Jay Venkatesan (51 yo)
5.1yrs
Permanencia
US$1,518,849
Compensación
Dr. Jay R. Venkatesan, Ph D., M.D. MBA., serves as Chairman of Angion Biomedica Corp. since January 2022 and also serves as its President since January 2019 and has been its Chief Executive Officer & Direc...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 5.1yrs | US$1.52m | 3.98% $ 1.2m | |
| Executive VP | 3.4yrs | US$773.65k | 0.048% $ 14.6k | |
| Chief Financial Officer | 3yrs | US$1.38m | 0.013% $ 4.0k | |
| Vice President of Human Resources | 3.7yrs | sin datos | sin datos |
3.5yrs
Permanencia media
53yo
Promedio de edad
Equipo directivo experimentado: ANGN's management team is considered experienced (3.5 years average tenure).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 5.1yrs | US$1.52m | 3.98% $ 1.2m | |
| Lead Independent Non-Employee Director | 5.2yrs | US$93.78k | 3.25% $ 978.7k | |
| Independent Non-Employee Director | 3.4yrs | US$76.78k | 0.27% $ 80.3k | |
| Independent Non-Employee Director | 3.2yrs | US$81.28k | 0.062% $ 18.7k | |
| Chairperson of Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Non-Employee Director | 3.4yrs | US$78.78k | 0.031% $ 9.4k | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Chairman Emeritus | 25.2yrs | US$854.33k | 5.61% $ 1.7m | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos |
4.3yrs
Permanencia media
74yo
Promedio de edad
Junta con experiencia: ANGN's board of directors are considered experienced (4.3 years average tenure).